Mid-Substance Achilles Tendinopathy
Investigational use for chronic mid-substance Achilles tendinopathy; evidence limited to isolated single-patient reports.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for Achilles tendinopathy. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational; only isolated single-patient reports exist.
- What evidence exists?
- No peer-reviewed clinical study of leech therapy in Achilles tendinopathy was identified; the few human reports found are isolated single-patient case studies. Tier C (investigational). There are no controlled trials. Evidence-based first-line management is an eccentric calf-loading program (Alfredson protocol or heavy-slow resistance), with extracorporeal shockwave therapy for non-responders. Insertional tendinopathy responds less well to eccentric loading; PRP and surgical options have varying evidence.
- Main risks
- Bleeding from bite sites for 6 to 24 hours after detachment
- Bruising and tenderness over the posterior calf and Achilles area for 5 to 14 days
- Local skin infection or Aeromonas infection
- Allergic reaction to leech saliva
- Temporary worsening of Achilles pain after the procedure
- Substitution for eccentric loading or shockwave therapy, which have stronger evidence
- Risk if a leech is placed too close to a small tendon rupture or partial tear
- Delay of orthopedic evaluation if rupture is suspected
- Iron-deficiency anemia from cumulative blood loss across multiple sessions
- Tendon rupture if leeches are placed inappropriately or if tendon is already significantly degenerated
- Small Y-shaped bite marks or skin colour changes at the bite sites, which usually fade over weeks to months
- Who should not consider this
- Patients with suspected or confirmed acute Achilles rupture (surgical or orthopedic evaluation)
- Patients within 4 weeks of local corticosteroid injection
- Patients with insertional Achilles tendinopathy (response is poorer; consider shockwave or surgical evaluation)
- Patients with active Achilles bursitis or infection
- Patients on anticoagulants or with anemia
- Patients who have not engaged with an eccentric loading program
- Patients with imaging-confirmed partial tendon tear (different management needed)
- What to ask your clinician
- Have I had a confirmed diagnosis of mid-substance tendinopathy by exam and ultrasound or MRI?
- Have I completed at least 12 weeks of structured eccentric calf loading?
- Has extracorporeal shockwave therapy been considered?
- Has PRP or surgical evaluation been considered for refractory cases?
- Where exactly will the leech be placed — confirm mid-substance, not insertional?
- What is the realistic expected VISA-A score change, given that only single-patient reports exist?
- Has ultrasound or MRI excluded a partial tendon tear?
- What is the rupture risk in a degenerated tendon, and how is it minimized?
- When to seek urgent care
- Sudden snap or pop in the calf with inability to push off the foot (rule out Achilles rupture)
- Severe sudden calf pain with swelling (rule out Achilles rupture or DVT)
- Loss of plantar flexion strength on testing
- Fever above 38.0 C / 100.4 F or chills
- Bleeding from a bite site lasting more than 24 hours
- Spreading redness, warmth, pus, or red streaks at any bite site
- Bleeding from a bite site that soaks through more than one dressing per hour
- Hives, facial or tongue swelling, throat tightness, or any difficulty breathing
- Sudden weakness, dizziness, fast heart rate, or fainting (possible severe blood loss)
What this does NOT mean
- It does not replace an eccentric calf-loading program, which is the evidence-based foundation.
- It does not heal a complete or partial Achilles tendon rupture; that needs orthopedic management.
- It is less effective for insertional Achilles tendinopathy.
- Only isolated single-patient reports exist; benefit beyond placebo or concurrent therapy is unknown.
Safety cross-references
Clinical Profile
- Category
- Musculoskeletal
- ICD-10
- M76.61, M76.62
- Safety tier
- Low
Evidence Summary
No controlled clinical trial or case series of leech therapy for chronic Achilles tendinopathy was identified in PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov or Russian- and German-language web searches; the only Achilles-specific case report found in journal literature is a single-patient Ayurvedic case study from 2025 (Achilles tendinitis, relief reported without scores), so there is no reliable evidence of improvement in VISA-A scores or pain. Any proposed mechanism (anti-inflammatory salivary peptides, reduction of peri-tendinous edema, or modulation of neovessel-driven nociception) is speculative and unproven in this condition. Evidence-based management — progressive eccentric/heavy-slow loading, activity modification, and extracorporeal shockwave therapy for recalcitrant cases — remains first-line. ASH position: any use of leech therapy for Achilles tendinopathy is investigational and supported only by isolated single-patient reports.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)
Contraindications
- Hemophilia or another bleeding disorder
- Taking anticoagulants (blood thinners such as warfarin or heparin)
- Anemia or suppressed blood formation
- Low blood pressure, shock, collapse or fainting
- Severe wasting (cachexia)
- Intolerance of leeches or a history of severe allergic reactions
- Pregnancy
- Stomach or duodenal ulcer, erosive gastritis
- Acute infectious disease or high fever
- Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
- Drinking alcohol at the time of treatment
- No consent from the patient
- Acute Achilles tendon rupture (surgical)
- Recent local corticosteroid injection (<4 weeks)
- Acute or partial Achilles tear (MRI confirmation needed; surgical or boot management)
- Fluoroquinolone-associated tendinopathy (taper drug; avoid invasive intervention until resolved)
Related Conditions
Plantar Fasciitis
Investigational use; no clinical study of leech therapy for plantar fasciitis was identified, and the rationale is mechanistic only.
Rotator Cuff Tendinopathy
Investigational use for non-surgical rotator cuff tendinopathy and chronic shoulder impingement; evidence limited to isolated case reports.
Lateral Epicondylitis (Tennis Elbow)
Off-label use with one small RCT (Bäcker 2011, n=40) in which a single leech session reduced pain more than topical diclofenac at day 7; the pain difference was no longer significant at day 45.
Knee Osteoarthritis
Off-label use; several small RCTs in knee OA report pain and function improvement with leeches versus NSAID gel, sham leech or TENS, though results against sham and TENS are mixed, and a 2022 trial against physiotherapy found no therapeutic effect.